AAAAAA

   
Results: 1-12 |
Results: 12
Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer
Authors: Backus, HHJ van Riel, JMGH van Groeningen, CJ Vos, W Dukers, DF Bloemena, E Wouters, D Pinedo, HM Peters, GJ
Citation: Hhj. Backus et al., Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer, ANN ONCOL, 12(6), 2001, pp. 779-785
5-Fluorouracil induced Fas upregulation associated with apoptosis in livermetastases of colorectal cancer patients
Authors: Backus, HHJ Dukers, DF van Groeningen, CJ Vos, W Bloemena, E Wouters, D van Riel, JMGH Smid, K Giaccone, G Pinedo, HM Peters, GJ
Citation: Hhj. Backus et al., 5-Fluorouracil induced Fas upregulation associated with apoptosis in livermetastases of colorectal cancer patients, ANN ONCOL, 12(2), 2001, pp. 209-216
Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker
Authors: ten Berge, RL Oudejans, JJ Dukers, DF Meijer, JWR Ossenkoppele, GJ Meijer, CJLM
Citation: Rl. Ten Berge et al., Percentage of activated cytotoxic T-lymphocytes in anaplastic large cell lymphoma and Hodgkin's disease: an independent biological prognostic marker, LEUKEMIA, 15(3), 2001, pp. 458-464
Anaplastic large cell lymphoma: what's in a name?
Authors: Ten Berge, RL Oudejans, JJ Dukers, DF Meijer, CJLM
Citation: Rl. Ten Berge et al., Anaplastic large cell lymphoma: what's in a name?, J CLIN PATH, 54(6), 2001, pp. 494-495
Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype
Authors: Dukers, DF Vermeer, MH Jaspars, LH Sander, CA Flaig, MJ Vos, W Willemze, R Meijer, CJLM
Citation: Df. Dukers et al., Expression of killer cell inhibitory receptors is restricted to true NK cell lymphomas and a subset of intestinal enteropathy-type T cell lymphomas with a cytotoxic phenotype, J CLIN PATH, 54(3), 2001, pp. 224-228
All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ
Authors: Dukers, DF Oudejans, JJ Jaspars, EH Gras, M Vos, W Middeldorp, JM Meijer, CJLM Bloemena, E
Citation: Df. Dukers et al., All infiltrating T-lymphocytes in Hodgkin's disease express immunohistochemically detectable T-cell receptor zeta-chains in situ, HISTOPATHOL, 36(6), 2000, pp. 544-550
Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease
Authors: Dukers, DF Jaspars, LH Vos, W Oudejans, JJ Hayes, D Cillessen, S Middeldorp, JM Meijer, CJLM
Citation: Df. Dukers et al., Quantitative immunohistochemical analysis of cytokine profiles in Epstein-Barr virus-positive and -negative cases of Hodgkin's disease, J PATHOLOGY, 190(2), 2000, pp. 143-149
Direct immunosuppressive effects of EBV-encoded latent membrane protein 1
Authors: Dukers, DF Meij, P Vervoort, MBHJ Vos, W Scheper, RJ Meijer, CJLM Bloemena, E Middeldorp, JM
Citation: Df. Dukers et al., Direct immunosuppressive effects of EBV-encoded latent membrane protein 1, J IMMUNOL, 165(2), 2000, pp. 663-670
The M-r 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines
Authors: Schroeijers, AB Siva, AC Scheffer, GL de Jong, MC Bolick, SCE Dukers, DF Slootstra, JW Meloen, RH Wiemer, E Kickhoefer, VA Rome, LH Scheper, RJ
Citation: Ab. Schroeijers et al., The M-r 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines, CANCER RES, 60(4), 2000, pp. 1104-1110
A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas
Authors: Dukers, DF ten Berge, RL Oudejans, JJ Pulford, K Hayes, D Misere, JFMM Ossenkoppele, GJ Jaspars, LH Willemze, R Meijer, CJLM
Citation: Df. Dukers et al., A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas, J CLIN PATH, 52(2), 1999, pp. 129-136
Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma
Authors: ten Berge, RL Dukers, DF Oudejans, JJ Pulford, K Ossenkoppele, GJ de Jong, D Misere, JFMM Meijer, CJLM
Citation: Rl. Ten Berge et al., Adverse effects of activated cytotoxic T lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma, BLOOD, 93(8), 1999, pp. 2688-2696
Untitled
Authors: Oudejans, JJ Dukers, DF ten Berge, RL Meijer, CJLM
Citation: Jj. Oudejans et al., Untitled, AM J PATH, 155(1), 1999, pp. 325-325
Risultati: 1-12 |